C9orf72 and amyotrophic lateral sclerosis: Through the study of individuals that carry a mutation in C9orf72 or other ALS-associated genes, Benatar and colleagues found that NfL in asymptomatic mutation carriers was elevated above the range seen in healthy individuals as early as 12 months prior to the earliest clinical symptoms (78).